|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/00 | |
| A61P 31/12 |
| (11) | Number of the document | 3311824 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17194591.8 |
| Date of filing the European patent application | 2014-02-05 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361761133 P | 2013-02-05 | US |
| (72) |
WEISKOPF, Kipp, US
HASENKRUG, Kim J., US
STODDART, Cheryl A., US
MCCUNE, Joseph M., US
WEISSMAN, Irving L., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
The United States of America, as represented by The Secretary, Department of Health and Human Services, 6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, Maryland 20892-7660, US The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US |
| (54) | CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE |
| CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE |